v3.24.1.u1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation, Stock Options, Activity
A summary of stock option activity for the three months ended March 31, 2024 is as follows:

Shares Under OptionWeighted- Average Exercise PriceWeighted- Average Contractual LifeAggregate Intrinsic Value

(in thousands)(in thousands)
Outstanding at December 31, 20234,262 $8.65 
Granted130 $9.20 
Expired(7)$15.30 
Outstanding at March 31, 20244,385 $8.66 5.3 years$18,357 
Exercisable at March 31, 20243,781 $7.70 4.8 years$18,036 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The weighted-average input assumptions used by the Company were as follows:
Three Months Ended
March 31, 2024March 31, 2023
Expected term (in years)5.05.0
Risk-free interest rate3.93 %3.99 %
Expected volatility84 %84 %
Dividend yield— %— %
The weighted-average input assumptions used by the Company were as follows:
Three Months Ended
March 31, 2024March 31, 2023
Performance period (in years)
3.03.0
Risk-free interest rate4.05 %4.19 %
Expected volatility of Magnite87 %94 %
Expected volatility of selected peer companies55 %64 %
Expected correlation coefficients of Magnite0.590.62
Expected correlation coefficients of selected peer companies0.470.54
Dividend yield— %— %
Schedule of Nonvested Restricted Stock Units Activity
A summary of restricted stock unit ("RSU") activity for the three months ended March 31, 2024 is as follows:
Number of SharesWeighted-Average Grant Date Fair Value
(in thousands)
Restricted stock units outstanding at December 31, 2023
11,450 $12.63 
Granted6,673 $9.20 
Canceled(216)$10.30 
Vested and released
(2,363)$11.90 
Restricted stock units outstanding and unvested at March 31, 2024
15,544 $11.30 
Schedule of Nonvested Performance-Based Units Activity
A summary of PSU activity for the three months ended March 31, 2024 is as follows:
Number of SharesWeighted-Average Grant Date Fair Value
(in thousands)
Outstanding at December 31, 2023
967 $18.17 
Granted486 $11.76 
Outstanding at March 31, 2024
1,453 $16.03 
Schedule of Stock Based Compensation Expense
Total stock-based compensation expense recorded in the condensed consolidated statements of operations was as follows:
Three Months Ended
March 31, 2024March 31, 2023
(in thousands)
Cost of revenue$500 $468 
Sales and marketing8,236 7,405 
Technology and development5,416 5,446 
General and administrative6,679 5,825 
Merger, acquisition, and restructuring costs— 143 
Total stock-based compensation expense$20,831 $19,287